Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
T Cell Types and Functions01:24

T Cell Types and Functions

2.9K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Cardiorespiratory Fitness on Cytotoxic T Cell Metabolism and Function.

Medicine and science in sports and exercise·2026
Same author

Microporous annealed particle scaffolds avoid foreign body response by down regulating complement-fibroblast-macrophage signaling loop.

bioRxiv : the preprint server for biology·2026
Same author

Kinematics-based assessment of reaching and grasping movements in LRN ablated animals identifies a role for the LRN in endpoint stabilization and reach timing.

bioRxiv : the preprint server for biology·2026
Same author

Lung adventitial fibroblasts support type 2 Tregs to shape the response to influenza infection.

bioRxiv : the preprint server for biology·2026
Same author

Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.

Clinical reviews in allergy & immunology·2026
Same author

Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering.

Science (New York, N.Y.)·2026

Related Experiment Video

Updated: Feb 28, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

11.1K

TGF-β1 Suppresses IL-33-Induced Mast Cell Function.

Victor S Ndaw1, Daniel Abebayehu2, Andrew J Spence1

  • 1Department of Biology, Virginia Commonwealth University, Richmond, VA 23284.

Journal of Immunology (Baltimore, Md. : 1950)
|June 23, 2017
PubMed
Summary
This summary is machine-generated.

Transforming growth factor-beta 1 (TGF-β1) broadly inhibits mast cell activation. This study shows TGF-β1 suppresses Interleukin-33 (IL-33)-induced responses in mast cells, impacting allergic disease pathways.

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.9K

Related Experiment Videos

Last Updated: Feb 28, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

11.1K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

11.9K

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Transforming growth factor-beta 1 (TGF-β1) is implicated in various diseases.
  • Previous studies show TGF-β1 suppresses IgE-mediated mast cell activation.
  • Interleukin-33 (IL-33) activates mast cells and enhances IgE-mediated responses.

Purpose of the Study:

  • To investigate the effects of TGF-β on IL-33-mediated mast cell activation.
  • To determine if TGF-β modulates IL-33-induced signaling pathways and cytokine production.
  • To assess TGF-β's impact on combined IL-33 and IgE-mediated mast cell activation.

Main Methods:

  • Culturing bone marrow-derived mast cells with TGF-β1, β2, or β3.
  • Measuring cytokine production (TNF, IL-6, IL-13, MCP-1) via ELISA.
  • Assessing intracellular signaling pathways (Akt, ERK phosphorylation) and transcription factors (NF-κB, AP-1).
  • Administering TGF-β1 in vivo to assess systemic cytokine levels and evaluating human mast cell responses.

Main Results:

  • TGF-β isoforms reduced IL-33-mediated cytokine production in a dose-dependent manner.
  • TGF-β1 inhibited IL-33-induced Akt/ERK phosphorylation and NF-κB/AP-1 transcription.
  • In vivo, TGF-β1 suppressed IL-33-induced systemic cytokines and human mast cell activation.
  • TGF-β1 diminished the combined effects of IL-33 and IgE on mast cells.

Conclusions:

  • TGF-β isoforms provide broad inhibitory signals to activated mast cells.
  • TGF-β1 significantly dampens IL-33-mediated mast cell activation pathways.
  • These findings highlight TGF-β's potential role in regulating allergic inflammation.